Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This target represents a heterogeneous collection of biological materials and microorganisms rather than a single defined molecular entity. It encompasses necrotic (devitalized) tissue, proteinaceous debris such as slough and eschar, and a diverse range of microbial flora including bacteria, fungi, and viruses [1, 2]. This category is primarily associated with the action of topical antiseptics, disinfectants, and enzymatic debriding agents used in wound management and infection control [1, 3]. Antiseptics like povidone-iodine and hydrogen peroxide exert their effects through non-specific mechanisms such as oxidation and protein denaturation, which disrupt the structural integrity and metabolic processes of a wide variety of microbes [3, 4]. Debriding agents, including enzymes like collagenase, specifically target and hydrolyze necrotic protein substrates to facilitate the removal of non-viable tissue from wound beds, thereby promoting the inflammatory and proliferative phases of healing [2]. Because these targets are non-specific, the primary therapeutic challenge involves achieving high efficacy against pathogens and debris while minimizing collateral damage to healthy, regenerating host tissues [1, 2]. Sources: [1] StatPearls. Antiseptics and Disinfectants. https://www.ncbi.nlm.nih.gov/books/NBK539814/ [2] StatPearls. Wound Debridement. https://www.ncbi.nlm.nih.gov/books/NBK507882/ [3] DrugBank. Hydrogen Peroxide. https://go.drugbank.com/drugs/DB01107 [4] PubChem. Povidone-iodine. https://pubchem.ncbi.nlm.nih.gov/compound/Povidone-iodine
Non-specific oxidation, protein denaturation, and enzymatic hydrolysis of necrotic debris and microbial components.
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Non-specific tissue and necrotic protein substrates; broad microbial flora.